Upstart Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 10, 2026
UPST$20.41-8.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Cash flows from operating activities | |||
| Net income (loss) | $(240,132) | $(128,581) | $53,601 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Change in fair value of loans | 190,320 | 125,002 | (113,672) |
| Change in fair value of servicing assets | 22,171 | 16,490 | 18,646 |
| Change in fair value of servicing liabilities | (2,013) | (1,246) | (942) |
| Change in fair value of beneficial interest assets | 21,672 | 5,151 | (33,184) |
| Change in fair value of beneficial interest liabilities | 4,817 | 12,568 | 16,579 |
| Change in fair value of other financial instruments | (2,145) | 4,130 | (6,921) |
| Stock-based compensation | 175,039 | 133,400 | 131,950 |
| Gain on loan servicing rights, net | (13,713) | (15,449) | (28,003) |
| Gain on debt extinguishment | — | (33,361) | (7,246) |
| Depreciation and amortization | 24,903 | 20,549 | 24,835 |
| Loan premium amortization | (3,869) | (17,021) | (49,149) |
| Non-cash interest expense and other | 3,057 | 3,217 | 8,607 |
| Net changes in operating assets and liabilities: | |||
| Purchases of loans held-for-sale | (3,006,510) | (4,309,268) | (9,072,905) |
| Proceeds from sale of loans held-for-sale | 2,514,627 | 4,101,937 | 8,679,462 |
| Principal payments received for loans held-for-sale | 189,746 | 192,889 | 187,660 |
| Principal payments received for loans held by consolidated securitization | 24,832 | 47,997 | 37,885 |
| Settlements of beneficial interest liabilities, net | (596) | (6,700) | (21,598) |
| Proceeds from beneficial interest assets (derivatives) | — | — | 4,602 |
| Settlements of beneficial interest assets (derivatives) | — | — | (4,575) |
| Other assets | (8,932) | (8,690) | (10,831) |
| Operating lease liability and right-of-use asset | (6,822) | (807) | (2,084) |
| Payable to investors for beneficial interest assets | 5,792 | — | — |
| Accrued expenses and other liabilities | (3,956) | 44,124 | 39,558 |
| Net cash provided by (used in) operating activities | (111,712) | 186,331 | (147,725) |
| Cash flows from investing activities | |||
| Purchases and originations of loans held-for-investment | (157,223) | (323,096) | (1,033,027) |
| Proceeds from sale of loans held-for-investment | 972 | — | 395,731 |
| Principal payments received for loans held-for-investment | 102,446 | 145,266 | 320,364 |
| Principal payments received for notes receivable and repayments of residual certificates | 4,328 | 5,917 | 23,051 |
| Acquisition and settlements of beneficial interest assets (hybrid instruments) | (56,892) | (67,753) | (3,438) |
| Proceeds from beneficial interest assets (hybrid instruments) | — | 11,930 | 142,902 |
| Issuance of line of credit receivable | — | — | (7,862) |
| Repayments of line of credit receivable | — | — | 3,515 |
Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Purchases of property and equipment | (1,527) | (837) | (347) |
| Capitalized software costs | (10,559) | (9,153) | (18,060) |
| Net cash used in investing activities | (118,455) | (237,726) | (177,171) |
| Cash flows from financing activities | |||
| Proceeds from borrowings | 626,910 | 387,281 | 294,218 |
| Proceeds from convertible notes issuance, net of debt issuance costs paid to lender | — | 913,440 | 678,270 |
| Payment of debt issuance costs to third parties | — | (3,945) | (3,150) |
| Repayments of borrowings | (575,937) | (357,352) | (317,097) |
| Payments for repurchases of convertible notes | — | (325,344) | (224,154) |
| Purchase of capped calls | — | (40,883) | (55,200) |
| Settlement of capped calls | — | 580 | 564 |
| Principal payments made on securitization notes | (23,320) | (55,368) | (40,592) |
| Payable to investors | (48,781) | 12,385 | 47,486 |
| Proceeds from issuance of securitization notes | 165,318 | — | — |
| Net proceeds related to stock-based award activities | 21,297 | 29,077 | 25,300 |
| Net cash provided by financing activities | 165,487 | 559,871 | 405,645 |
| Change in cash, cash equivalents and restricted cash | (64,680) | 508,476 | 80,749 |
| Cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash at beginning of year | 532,467 | 467,787 | 976,263 |
| Cash, cash equivalents and restricted cash at end of year | $467,787 | $976,263 | $1,057,012 |
| Supplemental disclosures of cash flow information | |||
| Cash paid for interest | $36,547 | $43,119 | $43,483 |
| Cash paid for income taxes, net | (658) | 258 | 590 |
| Supplemental disclosures of non-cash investing and financing activities | |||
| Beneficial interests obtained in connection with loan sales | $— | $90,565 | $325,675 |
| Securities retained under unconsolidated securitization transactions | 13,172 | 13,001 | 95,880 |
| Issuance of line of credit receivable | — | 54,780 | 51,599 |
| Capitalized stock-based compensation expense | 6,666 | 4,320 | 9,382 |
| Repayments of line of credit receivable | — | — | 1,761 |
| Settlement of borrowings in connection with loan sale | — | 221,749 | — |
| Securities retained under consolidated securitization transaction | 44,763 | — | — |
| Beneficial interest assets included in payable to investors | 5,792 | — | — |
Consolidated Statements of Cash Flows (Continued)
The following presents cash, cash equivalents and restricted cash by category within the consolidated balance sheets:
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2025 | |
| Cash and cash equivalents | $788,422 | $652,388 |
| Restricted cash | 187,841 | 404,624 |
| Total cash, cash equivalents and restricted cash | $976,263 | $1,057,012 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.